AZA-peptide protease inhibitors

Details for Australian Patent Application No. 2007275689 (hide)

Owner Gilead Sciences, Inc.

Inventors Xu, Lianhong; Cannizzaro, Carina E.; Chen, James M.; Swaminathan, Sundaramoorthi; Mitchell, Michael L.; Desai, Manoj C.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007275689

PCT Pub. Number WO2008/011116

Priority 60/832,459 21.07.06 US

Filing date 19 July 2007

Wipo publication date 24 January 2008

International Classifications

C07D 493/04 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

A61K 31/34 (2006.01) - having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

A61K 31/443 (2006.01)

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

29 January 2009 PCT application entered the National Phase

  PCT publication WO2008/011116 Priority application(s): WO2008/011116

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007275690-Antiviral protease inhibitors

2007275686-Thiadiazolidinone derivatives